Persistent Reflux Symptoms in the Proton Pump Inhibitor Era: The Changing Face of Gastroesophageal Reflux Disease
To access this article, please choose from the options below
Conflicts of interest The authors disclose the following: Nicholas J. Shaheen receives research funding from AstraZeneca, BARRX Medical, CSA Medical, Oncoscope Procter & Gamble, and Takeda, and is a consultant for AstraZeneca, CSA Medical, Oncoscope, and Takeda. Evan S. Dellon receives investigator-initiated research funding from AstraZeneca.
PII: S0016-5085(10)00744-4
doi:10.1053/j.gastro.2010.05.016
© 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

